🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To determine the safety and efficacy of azithromycin, rifabutin and ethambu...
Status
Completed
Location
The University of Texas Health Science Center at Tyler
Start Date
1994-12
Trial ID
NCT00598962
Treatments Being Tested
This study will be a phase I, open label, two arm, fixed sequence crossover...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-05
Trial ID
NCT01231542
Treatments Being Tested
The overall aim of the project is to evaluate rifabutin (RBT) as a replacem...
Status
Completed
Location
Pham Ngoc Tach Hospital
Start Date
2010-06
Trial ID
NCT00651066
An open label extension to the RHB-104-01 Study....
Status
Completed
Location
Digestive Care Associates, Inc., 1000 Laurel Street
Start Date
2017-03-18
Trial ID
NCT03009396
This is a prospective, single-center, fixed-sequence, nonrandomized, open-l...
Status
Completed
Location
University of Southern California
Start Date
2022-05-09
Trial ID
NCT04840862
Treatments Being Tested
Primary objective: To determine the rate of confirmed treatment failure an...
Status
Completed
Location
Central Arkansas Veterans Health System
Start Date
1999-02
Trial ID
NCT00023361
Treatments Being Tested
The purpose of this study is to study the safety, tolerability and pharmaco...
Status
Terminated
Location
Site Reference ID/Investigator# 11441
Start Date
2008-08
Trial ID
NCT00743470
Treatments Being Tested
Open label pharmacokinetic RBT dose-finding study in young (≤ 5 year old) H...
Status
Unknown
Location
Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, WHI, University of the Witwatersrand
Start Date
2010-11
Trial ID
NCT01259219
Treatments Being Tested
The aim of this study is to determine the effectiveness of rifabutin triple...
Status
Unknown
Location
Multiple Locations
Start Date
2021-05-01
Trial ID
NCT04652284
Treatments Being Tested